Coverage / LON:AVCT / Trade Card

LON:AVCT

Avacta Group Plc

SPECULATIVE BUY 2026-09-02 Data 10 days old 64.88p Healthcare - BiotechnologyAWAIT ENTRY
ACTIONABLEMethodology gates passed
49

Position levels

Currenttoday
64.88p
Buy <=wait / entry
48.00p
Trim >=take some off
68.00p
Thesis breakThe thesis would be invalidated by a clinical hold, dose-limiting toxicity or ef...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case16%100 / 10016.0
Base case48%62 / 10029.8
Bear case36%10 / 1003.6
Weighted conviction49 / 100 - SPECULATIVE BUY

Top risks

  • Upcoming earnings report scheduled for 05/10/2026
  • Analyst median 12-month price target of 72 GBX representing 5.88% upside from recent prices near 68 GBX
  • Reported annual 2025 losses of -10.57 per share with revenues of only 133k
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.